Bionic Commando: Rearmed

Known as: BCR, Ben Judd (Producer), Bionic Commando Rearmed - The Soundtrack 
Bionic Commando Rearmed (バイオニック コマンドー マスターD復活計画, Bionic Commando: Master D Resurrection Project in Japan) is an enhanced remake of the 1988 Nintendo… (More)
Wikipedia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Tyrosine kinase inhibitors (TKIs) are widely used to treat patients with leukaemia driven by BCR–ABL1 (ref. 1) and other… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 13
  • figure 4
Is this relevant?
2010
2010
Optimal deployment, with respect to locations, capacity sizes, and types of distributed energy resources (DERs), which are the… (More)
  • table I
  • table II
  • figure 1
  • table III
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The clinical success of the ABL tyrosine kinase inhibitor imatinib in chronic myeloid leukaemia (CML) serves as a model for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
c-Abl is normally regulated by an autoinhibitory mechanism, the disruption of which leads to chronic myelogenous leukemia. The… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2000
Highly Cited
2000
BACKGROUND Chronic myeloid leukemia is caused by a chromosomal translocation that results in an oncogenic fusion protein, Bcr-Abl… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
1999
Review
1999
Prospective studies on the detection of minimal residual disease (MRD) in acute leukemia patients have shown that large-scale MRD… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • table 4
Is this relevant?
Highly Cited
1988
Highly Cited
1988
The Philadelphia chromosome is present in more than 95% of chronic myeloid leukemia patients and 13% of acute lymphocytic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?